Literature DB >> 19152843

T box transcription antitermination riboswitch: influence of nucleotide sequence and orientation on tRNA binding by the antiterminator element.

Hamid Fauzi1, Akwasi Agyeman, Jennifer V Hines.   

Abstract

Many bacteria utilize riboswitch transcription regulation to monitor and appropriately respond to cellular levels of important metabolites or effector molecules. The T box transcription antitermination riboswitch responds to cognate uncharged tRNA by specifically stabilizing an antiterminator element in the 5'-untranslated mRNA leader region and precluding formation of a thermodynamically more stable terminator element. Stabilization occurs when the tRNA acceptor end base pairs with the first four nucleotides in the seven nucleotide bulge of the highly conserved antiterminator element. The significance of the conservation of the antiterminator bulge nucleotides that do not base pair with the tRNA is unknown, but they are required for optimal function. In vitro selection was used to determine if the isolated antiterminator bulge context alone dictates the mode in which the tRNA acceptor end binds the bulge nucleotides. No sequence conservation beyond complementarity was observed and the location was not constrained to the first four bases of the bulge. The results indicate that formation of a structure that recognizes the tRNA acceptor end in isolation is not the determinant driving force for the high phylogenetic sequence conservation observed within the antiterminator bulge. Additional factors or T box leader features more likely influenced the phylogenetic sequence conservation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19152843      PMCID: PMC2656570          DOI: 10.1016/j.bbagrm.2008.12.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1.

Authors:  F Ducongé; J J Toulmé
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Sequence requirements for terminators and antiterminators in the T box transcription antitermination system: disparity between conservation and functional requirements.

Authors:  Frank J Grundy; Tessa R Moir; Margaret T Haldeman; Tina M Henkin
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

3.  Association of an RNA kissing complex analyzed using 2-aminopurine fluorescence.

Authors:  M Rist; J Marino
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

4.  Parallel-stranded DNA with mixed AT/GC composition: role of trans G.C base pairs in sequence dependent helical stability.

Authors:  A K Shchyolkina; O F Borisova; M A Livshits; G E Pozmogova; B K Chernov; R Klement; T M Jovin
Journal:  Biochemistry       Date:  2000-08-22       Impact factor: 3.162

5.  Crystal structure of the lysine riboswitch regulatory mRNA element.

Authors:  Andrew D Garst; Annie Héroux; Robert P Rambo; Robert T Batey
Journal:  J Biol Chem       Date:  2008-07-01       Impact factor: 5.157

6.  In vitro structure-function studies of the Bacillus subtilis tyrS mRNA antiterminator: evidence for factor-independent tRNA acceptor stem binding specificity.

Authors:  Melinda S Gerdeman; Tina M Henkin; Jennifer V Hines
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

7.  tRNA determinants for transcription antitermination of the Bacillus subtilis tyrS gene.

Authors:  F J Grundy; J A Collins; S M Rollins; T M Henkin
Journal:  RNA       Date:  2000-08       Impact factor: 4.942

8.  In vitro selection of DNA aptamers against the HIV-1 TAR RNA hairpin.

Authors:  Dalila Sekkai; Eric Dausse; Carmelo Di Primo; Fabien Darfeuille; Claudine Boiziau; Jean-Jacques Toulmé
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2002-08

9.  tRNA-mediated transcription antitermination in vitro: codon-anticodon pairing independent of the ribosome.

Authors:  Frank J Grundy; Wade C Winkler; Tina M Henkin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-06       Impact factor: 11.205

10.  Transfer RNA-mediated antitermination in vitro.

Authors:  Harald Putzer; Ciarán Condon; Dominique Brechemier-Baey; Renata Brito; Marianne Grunberg-Manago
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

View more
  7 in total

1.  Direct evaluation of tRNA aminoacylation status by the T-box riboswitch using tRNA-mRNA stacking and steric readout.

Authors:  Jinwei Zhang; Adrian R Ferré-D'Amaré
Journal:  Mol Cell       Date:  2014-06-19       Impact factor: 17.970

2.  Lineage-specific insertions in T-box riboswitches modulate antibiotic binding and action.

Authors:  Nikoleta Giarimoglou; Adamantia Kouvela; Ioanna Patsi; Jinwei Zhang; Vassiliki Stamatopoulou; Constantinos Stathopoulos
Journal:  Nucleic Acids Res       Date:  2022-06-10       Impact factor: 19.160

3.  Factors that influence T box riboswitch efficacy and tRNA affinity.

Authors:  C Zeng; S Zhou; S C Bergmeier; J V Hines
Journal:  Bioorg Med Chem       Date:  2015-07-16       Impact factor: 3.641

Review 4.  Structure and mechanism of the T-box riboswitches.

Authors:  Jinwei Zhang; Adrian R Ferré-D'Amaré
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-05-08       Impact factor: 9.957

5.  Interfacing medicinal chemistry with structural bioinformatics: implications for T box riboswitch RNA drug discovery.

Authors:  Franziska Jentzsch; Jennifer V Hines
Journal:  BMC Bioinformatics       Date:  2012-03-13       Impact factor: 3.169

6.  A glyS T-box riboswitch with species-specific structural features responding to both proteinogenic and nonproteinogenic tRNAGly isoacceptors.

Authors:  Maria Apostolidi; Nizar Y Saad; Denis Drainas; Spyros Pournaras; Hubert D Becker; Constantinos Stathopoulos
Journal:  RNA       Date:  2015-08-14       Impact factor: 4.942

Review 7.  Unboxing the T-box riboswitches-A glimpse into multivalent and multimodal RNA-RNA interactions.

Authors:  Jinwei Zhang
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-07-06       Impact factor: 9.349

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.